Guided Therapeutics (GTHP) FCF Margin Growth (5y) (2016 - 2025)
Guided Therapeutics (GTHP) FCF Margin Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 127,468.00 |
| Sep 30, 2025 | 30,327.00 |
| Dec 31, 2024 | -3.19 Mn |
| Mar 31, 2024 | -63,333.00 |
| Dec 31, 2023 | -30,952.00 |
| Jun 30, 2023 | 161,705.00 |
| Mar 31, 2023 | 738,182.00 |
| Sep 30, 2022 | -2.06 Mn |
| Jun 30, 2022 | -746,943.00 |
| Mar 31, 2022 | -192,667.00 |
| Dec 31, 2021 | 16,313.00 |
| Sep 30, 2021 | -379,474.00 |
| Dec 31, 2020 | -125,733.00 |
| Sep 30, 2020 | -61,494.00 |
| Sep 30, 2019 | -2.36 Mn |
| Jun 30, 2019 | -1.90 Mn |
| Mar 31, 2019 | -101,228.00 |
| Dec 31, 2018 | -80,348.00 |
| Sep 30, 2018 | -2.50 Mn |
| Mar 31, 2018 | -958,952.00 |